NO894295L - Fremgangsmaate for behandling av interstitiell cystitt. - Google Patents

Fremgangsmaate for behandling av interstitiell cystitt.

Info

Publication number: NO894295L
Authority: NO; Norway
Prior art keywords: cystite; interstitially; procedure; treatment; naltrexone
Prior art date: 1988-11-01

Application number

NO89894295A

Other languages

English (en)

Norwegian (no)

Other versions

NO894295D0 (no

Inventor

Fred P Sherman

Original Assignee

Baker Cummins Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-01

Filing date

1989-10-27

Publication date

1990-05-02

1989-10-27 Application filed by Baker Cummins Pharma filed Critical Baker Cummins Pharma

1989-10-27 Publication of NO894295D0 publication Critical patent/NO894295D0/no

1990-05-02 Publication of NO894295L publication Critical patent/NO894295L/no

Links

238000000034 method Methods 0.000 title abstract 2
WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 2
229960005297 nalmefene Drugs 0.000 abstract 2
229960003086 naltrexone Drugs 0.000 abstract 2
DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 abstract 2
208000005615 Interstitial Cystitis Diseases 0.000 abstract 1
239000003887 narcotic antagonist Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Threshing Machine Elements (AREA)

NO89894295A 1988-11-01 1989-10-27 Fremgangsmaate for behandling av interstitiell cystitt. NO894295L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/265,575 US4877791A (en)	1988-11-01	1988-11-01	Method of treatment for interestitial cystitis

Publications (2)

Publication Number	Publication Date
NO894295D0 NO894295D0 (no)	1989-10-27
NO894295L true NO894295L (no)	1990-05-02

Family

ID=23011021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO89894295A NO894295L (no)	1988-11-01	1989-10-27	Fremgangsmaate for behandling av interstitiell cystitt.

Country Status (11)

Country	Link
US (1)	US4877791A (de)
EP (1)	EP0367533B1 (de)
JP (1)	JPH07556B2 (de)
AT (1)	ATE102830T1 (de)
AU (1)	AU623189B2 (de)
CA (1)	CA2001996C (de)
DE (1)	DE68913907T2 (de)
DK (1)	DK541189A (de)
HK (1)	HK119994A (de)
NO (1)	NO894295L (de)
ZA (1)	ZA897823B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4857533A (en) *	1988-12-15	1989-08-15	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for autoimmune diseases
US4994466A (en) *	1990-06-14	1991-02-19	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for multiple sclerosis
US5057322A (en) *	1990-08-10	1991-10-15	Baker Cummins Dermatologicals, Inc.	Method of treating mast cell disease
US5145859A (en) *	1991-03-20	1992-09-08	Case Western Reserve University	Methods of treating interstitial cystitis and urethral syndrome
EP0820288B1 (de)	1995-03-03	2004-02-11	Endo Pharmaceuticals Inc.	Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
US5878750A (en) *	1996-11-14	1999-03-09	Clemens; Anton H.	Method of treating the syndrome of coronary heart disease risk factors in humans
US6203813B1 (en)	1997-01-13	2001-03-20	Lance L. Gooberman	Pharmaceutical delivery device and method of preparation therefor
EP1150699A4 (de) *	1999-02-01	2004-06-30	John Lezdey	Behandlung der blasen- und gastrointestinalen-mastozytose
US6528520B2 (en) *	2000-08-15	2003-03-04	Cpd, Llc	Method of treating the syndrome of coronary heart disease risk factors in humans
US6846831B2 (en)	2000-08-15	2005-01-25	Cpd, Llc	Method of treating the syndrome of lipodystrophy
US6262062B1 (en)	2000-08-15	2001-07-17	Cpd, Llc	Method of treating the syndrome of coronary heart disease risk factors in humans
WO2002081477A1 (en) *	2001-03-30	2002-10-17	Toray Industries, Inc.	7-substituted morphinane derivatives and medicinal use thereof
US7501433B2 (en) *	2002-05-17	2009-03-10	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
US6972291B2 (en) *	2002-07-02	2005-12-06	Bernstein Richard K	Method for reducing food intake
US8017622B2 (en) *	2003-05-16	2011-09-13	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
US20070243218A1 (en) *	2006-04-03	2007-10-18	Ellinghuysen Jerry A	Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
CN105724811A (zh) *	2008-12-16	2016-07-06	希尔氏宠物营养品公司	用于抑制陪伴动物的组胺路径的含抗氧化剂的食品组合物
WO2019227053A1 (en) *	2018-05-25	2019-11-28	Adamis Pharmaceuticals Corporation	Drug compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU538186B2 (en) *	1980-03-07	1984-08-02	Scotia Holdings Plc	Prostaglandin precursors
WO1987002586A2 (en) *	1985-10-29	1987-05-07	Key Pharmaceuticals, Inc.	Method and composition for blocking antigen-induced allergic responses
FR2609632B1 (fr) *	1987-01-21	1991-03-29	Shelly Marc	Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US4880813A (en) *	1988-07-22	1989-11-14	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for allergic rhinitis
US4857533A (en) *	1988-12-15	1989-08-15	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for autoimmune diseases

1988
- 1988-11-01 US US07/265,575 patent/US4877791A/en not_active Expired - Fee Related
1989
- 1989-10-16 ZA ZA897823A patent/ZA897823B/xx unknown
- 1989-10-25 JP JP1279638A patent/JPH07556B2/ja not_active Expired - Lifetime
- 1989-10-27 AU AU43850/89A patent/AU623189B2/en not_active Ceased
- 1989-10-27 NO NO89894295A patent/NO894295L/no unknown
- 1989-10-30 DE DE68913907T patent/DE68913907T2/de not_active Expired - Fee Related
- 1989-10-30 AT AT89311177T patent/ATE102830T1/de not_active IP Right Cessation
- 1989-10-30 EP EP89311177A patent/EP0367533B1/de not_active Expired - Lifetime
- 1989-10-30 DK DK541189A patent/DK541189A/da not_active Application Discontinuation
- 1989-11-01 CA CA002001996A patent/CA2001996C/en not_active Expired - Fee Related
1994
- 1994-11-03 HK HK119994A patent/HK119994A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH07556B2 (ja)	1995-01-11
JPH02188525A (ja)	1990-07-24
US4877791A (en)	1989-10-31
AU4385089A (en)	1990-05-10
CA2001996A1 (en)	1990-05-01
HK119994A (en)	1994-11-11
NO894295D0 (no)	1989-10-27
DK541189D0 (da)	1989-10-30
EP0367533B1 (de)	1994-03-16
CA2001996C (en)	1996-07-23
DE68913907D1 (de)	1994-04-21
ZA897823B (en)	1990-07-25
DE68913907T2 (de)	1994-06-23
DK541189A (da)	1990-05-02
AU623189B2 (en)	1992-05-07
EP0367533A2 (de)	1990-05-09
EP0367533A3 (de)	1991-10-02
ATE102830T1 (de)	1994-04-15

Publication	Publication Date	Title
ZA899028B (en)	1990-08-29	Compound for treatment for autoimmune diseases
NO894295D0 (no)	1989-10-27	Fremgangsmaate for behandling av interstitiell cystitt.
EP0377272A3 (de)	1991-09-25	Verwendung von Nalmefen oder Naltrexon zur Herstellung eines Arzneimittels zur Entzündungsbehandlung der Arthritis und assoziierter entzündlicher Erkrankungen
EP0449247A3 (en)	1992-03-04	Pharmaceutical composition containing galanthamine for treating alcoholism
PH23867A (en)	1989-11-23	Method of treating parkinson's disease using indolone derivatives
ATE105482T1 (de)	1994-05-15	Behandlung von krebs mit somatostatin und mit analogen davon.
AU1189688A (en)	1988-08-10	Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
HUT58520A (en)	1992-03-30	Process for producing pharmaceutical composition suitable for treating impotence
ATE78687T1 (de)	1992-08-15	Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
EP0319962A3 (de)	1990-08-22	Piperidinyl-Methanol-Derivate zur Behandlung von Angstzuständen
ES2093357T3 (es)	1996-12-16	Metodo de tratamiento de la alopecia.
GR3025518T3 (en)	1998-02-27	Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
AU8166291A (en)	1992-02-13	Method of treating mast cell disease
AU2908389A (en)	1989-07-19	Device for administering medicaments by atomization in intubated or tracheotomized patients
IT9086204A0 (it)	1990-05-31	Metodo per la cura dell'impotenza erettiva maschile
GR900300082T1 (en)	1991-07-31	Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
FI900098A0 (fi)	1990-01-09	Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
HUT59307A (en)	1992-05-28	Process for producing pharmaceutical compositions comprising zofenopril and suitable for treating arthritis